Literature DB >> 19104460

Interaction between PON1 and population density in amyotrophic lateral sclerosis.

Frank P Diekstra1, Ana Beleza-Meireles, Nigel P Leigh, Christopher E Shaw, Ammar Al-Chalabi.   

Abstract

Paraoxonase polymorphisms have been associated with amyotrophic lateral sclerosis (ALS). Paraoxonases are detoxifying enzymes involved in the metabolism of organophosphates. We tested the hypothesis that genetic variation within paraoxonase genes would interact with the environmental exposure to paraoxonase substrates. We used population density in the location of residence of ALS patients as a surrogate marker for environmental exposure. Paraoxonase genotypes at previously associated single nucleotide polymorphisms rs662, rs854560, rs6954345, and rs11981433 were studied in 98 patients from the South East England ALS population-based register. A case-only analysis was carried out and median population density was used to categorize patients into rural or urban environments. We found a significant interaction with population density for marker rs854560 (L55M) in ALS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19104460     DOI: 10.1097/WNR.0b013e32831af220

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  8 in total

1.  The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis.

Authors:  Frank O Johnson; William D Atchison
Journal:  Neurotoxicology       Date:  2009-07-24       Impact factor: 4.294

2.  New considerations in the design of clinical trials for amyotrophic lateral sclerosis.

Authors:  James D Berry; Merit E Cudkowicz
Journal:  Clin Investig (Lond)       Date:  2011-10

3.  Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis.

Authors:  Carmen Martínez; Elena García-Martín; Julián Benito-León; Patricia Calleja; María Díaz-Sánchez; Diana Pisa; Hortensia Alonso-Navarro; Lucía Ayuso-Peralta; Dolores Torrecilla; José A G Agúndez; Félix Javier Jiménez-Jiménez
Journal:  Neuromolecular Med       Date:  2009-10-14       Impact factor: 3.843

Review 4.  ALS and FTD: an epigenetic perspective.

Authors:  Veronique V Belzil; Rebecca B Katzman; Leonard Petrucelli
Journal:  Acta Neuropathol       Date:  2016-06-09       Impact factor: 17.088

5.  The association between ALS and population density: A population based study.

Authors:  Kirsten M Scott; Kumar Abhinav; Lokesh Wijesekera; Jeban Ganesalingam; Laura H Goldstein; Anna Janssen; Andrew Dougherty; Emma Willey; Biba R Stanton; Martin R Turner; Mary-Ann Ampong; Mohammed Sakel; Richard Orrell; Robin Howard; Christopher E Shaw; P Nigel Leigh; Ammar Al-Chalabi
Journal:  Amyotroph Lateral Scler       Date:  2010-10

6.  Neurological deaths of American adults (55-74) and the over 75's by sex compared with 20 Western countries 1989-2010: Cause for concern.

Authors:  Colin Pritchard; Emily Rosenorn-Lanng
Journal:  Surg Neurol Int       Date:  2015-07-23

7.  Genetic factors for survival in amyotrophic lateral sclerosis: an integrated approach combining a systematic review, pairwise and network meta-analysis.

Authors:  Wei-Ming Su; Xiao-Jing Gu; Qing-Qing Duan; Zheng Jiang; Xia Gao; Hui-Fang Shang; Yong-Ping Chen
Journal:  BMC Med       Date:  2022-06-27       Impact factor: 11.150

8.  Association between serum paraoxonase 1 activity and its polymorphisms with multiple sclerosis: a systematic review.

Authors:  Nader Salari; Shna Rasoulpoor; Amin Hosseinian-Far; Nazanin Razazian; Kamran Mansouri; Masoud Mohammadi; Aliakbar Vaisi-Raygani; Rostam Jalali; Shervin Shabani
Journal:  Neurol Sci       Date:  2020-10-23       Impact factor: 3.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.